VVP
SANA icon

Venture Visionary Partners’s Sana Biotechnology SANA Stock Holding History

Venture Visionary Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$643 – 1329
2022
Q2 		$643 Buy
+100
New +$637 ﹤0.01% 1632

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Venture Visionary Partners's SANA Position: Q3 2022 in Review

Venture Visionary Partners sold out of Sana Biotechnology (SANA) in Q3 2022, closing a stake of 100 shares — an estimated $643 sold.

Venture Visionary Partners first reported a position in SANA in Q2 2022 and held it in 1 quarter. The position peaked at $643 in Q2 2022. 125 funds tracked by Wall St. Rank hold SANA as of Q3 2022.

  • Venture Visionary Partners reported no remaining Sana Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 100 Sana Biotechnology shares in Q3 2022, an estimated $643.
  • Venture Visionary Partners first reported a position in Sana Biotechnology in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Sana Biotechnology position peaked at $643 in Q2 2022.
  • 125 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.